This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego
BOOK NOW
Menu
BOOK NOW
keyboard_arrow_right

Main Conference Day 3 - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
close
Main Conference Day 3 - PT (Pacific Time, GMT-08:00)
close
Showing 1 of 1 Streams
10:30am - 11:00am
Exploring Targeted, Non-pan-cytotoxic ADC Payloads Across Different Targets for Efficacy and Enhanced TI

We are investigating unique payloads by exploring agents that target cancer cell dependencies/vulnerabilities, or that have known or assumed safety liabilities or poor physicochemical properties that would benefit from delivery via antibodies. We will discuss early achievements in the development of these more targeted ADCs.

  • Gail Lewis, PhD - Distinguished Scientist, Discovery Oncology, Genentech
Main Conference Day 2
Filter
Streams
Formats
Choose Day